Tick-borne Disease, Acute Molecular Panel, Non-Lyme

Test Code

32338

CPT Codes
87468, 87469, 87478, 87484

Includes

Anaplasma Phagocytophilum DNA, Qualitative Real-Time PCR
Babesia microti DNA, Real-Time PCR
Borrelia miyamotoi DNA, Real-Time PCR, Miscellaneous
Ehrlichia chaffeensis DNA, Real-Time PCR

Preferred Specimen

3 mL whole blood collected in an EDTA (lavender-top) tube

Minimum Volume

1.5 mL

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

Room temperature: 48 hours
Refrigerated: 7 days
Frozen -20° C: 30 days
Frozen -70° C: Unacceptable

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)

Hemolysis • Heparin as an anticoagulant

Methodology
Real-Time Polymerase Chain Reaction

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule

See individual assays

Clinical Significance

Comprehensive molecular panel for the diagnosis of various tick-borne diseases provides a solution for physicians in that such a panel obviates the need to consider tests for individual agents, each of which may cause illness with overlapping geographic distributions and clinical presentations.

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.